. Nitric oxide and endothelin in oxygen-dependent regulation of vascular tone of human umbilical vein. Am J Physiol Heart Circ Physiol 285: H1730-H1737, 2003; 10.1152/ajpheart.00938.2002.-We investigated the possible contribution of nitric oxide (NO) and endothelin (ET) to oxygen-dependent regulation of human umbilical vein vascular tone by simultaneous registration of intracellular membrane potential and isometric tension of vessel strips with and without NO synthase inhibition [10
Ϫ4
M N -nitro-L-arginine methyl ester (L-NAME)], ETA receptor blockade (10 Ϫ5 M BQ-123), or ETB receptor blockade (10 Ϫ7 M BQ-788) at PO2 values in the bath solution between 5 and 104 mmHg. Increasing PO2 above the physiological intrauterine range resulted in depolarization and an increase of isometric tension, whereas lowering PO2 resulted in hyperpolarization and a decrease in isometric tension. Removal of the endothelium reversed these effects. At PO2 values below 39 mmHg, intact preparations treated with either L-NAME, BQ-788, or BQ-123 were more depolarized than controls. In the case of treatment with L-NAME or BQ-123, this was accompanied by an increase in isometric tension. We conclude that it is NO that mediates the hypoxic hyperpolarization and vasodilatation of the human umbilical vein and that ET, via activation of ETB1 receptors on endothelial cells, contributes to this effect. membrane potential; endothelium; nitric oxide synthase inhibition; endothelin receptor antagonism BLOOD FLOW FROM THE PLACENTA to the fetus is determined by the difference between fetal aortic blood pressure and umbilical vein blood pressure, which in turn depends on umbilical vein vascular tone. The contribution of umbilical vein vascular tone to the regulation of umbilical blood flow had been regarded as negligible, because the umbilical vein was thought to operate at maximal vasodilatation already at resting conditions (6) . However, a recent study (15) from our laboratory has revealed that the human umbilical vein is far from being a passive conduit, but is able to adjust its vascular tone in response to changes in local PO 2 . In particular, we found endothelium-dependent vasodilatation at hypoxia.
Because the human umbilical vein is thought to lack autonomic innervation (4, 21) , local mechanisms of regulation of vascular tone may be of particular relevance. Besides prostanoids, endothelial nitric oxide (NO) and endothelin (ET) are the most important locally released factors regulating vascular tone. There is a continuous basal release of NO from the vascular endothelium, and increased release of NO contributes to endothelium-dependent vasodilatation in response to various stimuli (16) . We therefore asked whether NO contributes to oxygen-dependent regulation of human umbilical vein vascular tone and studied the effects of inhibition of NO synthesis by N -nitro-L-arginine methyl ester (L-NAME) on membrane potential and isometric tension of intact human umbilical vein preparations at different local PO 2 values.
There is also evidence for a basal release of ET in the human vasculature (23) , and cultured endothelial cells from human umbilical veins are known to release ET spontaneously (12) . Production and release of ET are affected by a number of factors, including PO 2 (3, 17) . We hypothesized that ET contributed to oxygen-dependent regulation of human umbilical vein vascular tone. ET mediates its vasoconstricting effects via activation of ET A and ET B2 receptors located on vascular smooth muscle cells, whereas ET B1 receptors, located on vascular endothelial cells, mediate vasodilating effects of ET (3, 12) . We therefore studied the effect of selective blockade of ET A and ET B receptors on membrane potential and vascular tone of the human umbilical vein at different local PO 2 values. ET was first isolated from vascular endothelial cells (25) , but it has been reported that vascular smooth muscle cells from different vessels including human umbilical veins also produce ET (13, 26) . Thus we studied the effects of ET receptor blockade not only in intact but also in endotheliumdenuded preparations.
MATERIALS AND METHODS

Vessel Dissection
Human umbilical cords were obtained from normal fullterm deliveries after uneventful pregnancies. The study was approved by the local ethics committee. Within the first minutes of birth, cord segments were cut at least 10 cm from the infants, because the distal part of the human umbilical vein is thought to be definitely devoid of nerves (4, 21 (14) . At the end of our experiments, KCl was added to a final concentration of 0.05 M to test the viability of the preparations. All preparations except one responded with vigorous contractions. The results obtained from the one vessel that did not respond to KCl were excluded.
After the vein was carefully separated from the Wharton's jelly, vascular rings (0.5 cm in height) were allowed to equilibrate in Krebs solution gassed with 4% O 2-5% CO2-balance N2 at 37°C for 2 h. Vascular rings were then cut lengthwise to create vascular strips.
Removal of Endothelium
For experiments with endothelium-denuded preparations, the endothelial layer was gently scraped off by a scalpel just before the experiments. We confirmed the effectiveness of this method by a systematic functional evaluation in addition to a systematic immunohistochemical examination. When exposed to acetylcholine (10 Ϫ5 M), four endothelium-denuded umbilical vein preparations all responded with a sustained increase in isometric tension, whereas in the four control preparations with the endothelium left intact, isometric tension decreased. Additionally, seven endothelium-denuded preparations and seven intact preparations were fixed with formalin and embedded in paraffine. Endothelial cells were labeled with antibodies against surface antigens specific for these cells (monoclonal anti-CD31 and monoclonal anti-CD34, DakoCytomation; Glostrup, Denmark). These antibodies were made visible by the alkaline/anti-alkaline phosphatase method using fast red as a chromogen. All intact preparations revealed a homogeneous endothelial layer, whereas all endothelium-denuded preparations were negative for CD31 and CD34 and thus devoid of endothelial cells.
Registration of Isometric Tension and Intracellular Membrane Potential
Vascular strips were attached to an isometric tensionmeasuring device (KWS 522.C, K 52 C, Hottinger Baldwin; Darmstadt, Germany) to record the tension developed by the circularly oriented smooth muscle cells, which are the main portion of the muscular layer of the umbilical vein vessel wall (1, 21) . The preparations were superfused in a bathing chamber by Krebs solution at 30 ml/min, which applied a pretension of 1 g [equivalent to the wall stress of the human umbilical vein under resting conditions according to the LaPlace relationship applied to a cylindric vessel (7) ]. This pretension was repeatedly adjusted during an initial period of 5 min.
To record intracellular membrane potential simultaneously with mechanical tension, glass microelectrodes filled with KCl at a concentration of 3 M were inserted into the venous smooth muscle cells from the intimal surface by means of a micromanipulator (7, 24) . The electrodes were shielded to just below the tips. Their resistances ranged from 60 to 100 M⍀. Membrane potential was displayed on a large screen oscilloscope (SGM 43 BN 901 S/H 293, Knott; Mü nchen, Germany) and recorded by a personal computer. A sudden negative potential change was used as the criterion of a successful intracellular insertion, which reverted to zero upon withdrawal of the microelectrode.
Antagonist Treatment With L-NAME, BQ-123, and BQ-788
To inhibit NO synthase, L-NAME hydrochloride (Sigma; Taufkirchen (9) in Krebs solution gassed with 4% O2-5% CO2-balance N2 at 37°C. In preceding experiments, we tested whether the ET-blocking effects of these pretreatments were preserved during the duration of an individual experiment (2 h and 15 min). We found that the effects of pretreatment with BQ-123 or BQ-788 on the response of human umbilical vein preparations to ET-1 (10 Ϫ8 M) were virtually the same 15 min after pretreatment and 2 h and 15 min after pretreatment, respectively.
BQ-123 was dissolved in DMSO in distilled water and stored as aliquots at Ϫ20°C for Ͻ3 mo until use. The final concentration of DMSO in the preincubation solution was 0.01%. Up to 10-fold higher concentrations of DMSO have been shown to exert no effect on vascular tone under control conditions (22) . BQ-788 was dissolved in Krebs solution and stored as aliquots at Ϫ20°C for Ͻ3 mo until use.
Experimental Protocol
Krebs solution was equilibrated by a gas mixture of 5% CO 2, 0-14% O2, and balance N2. Gas partial pressures were measured in the Krebs solution of the bathing chamber just above the specimens by a combined PO 2-PCO2 electrode (TCM 3, Radiometer; Copenhagen, Denmark). PCO2 was 40 mmHg; PO2 could be varied stepwise among 5, 22, 39, 68, and 104 mmHg. Temperature was kept at 37°C, and pH between 7.20 Control 29
Values (in mV) are means Ϯ SE; n, no. of intact human umbilical vein preparations. L-NAME, N -nitro-L-arginine methyl ester. * P Ͻ 0.05 vs. control; † P Ͻ 0.01 vs. control; ‡ P Ͻ 0.001 vs. control at the same PO2; § P Ͻ 0.001, membrane potential at 5 vs. 104 mmHg. and 7.40. In individual series of experiments with matched pairs of untreated control preparations and treated preparations, variations of pH ranged from 0.04 to 0.11. Experiments were started at a PO 2 of 39 mmHg, a value close to the physiological human umbilical venous PO2 range [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] ]. Vessel strips were exposed to first decreasing (from 39 to 5 mmHg), then increasing (from 5 to 104 mmHg), and finally again to decreasing (from 104 to 39 mmHg) PO 2 for 15 min each, and intracellular membrane potential and isometric tension were recorded continuously. The same protocol was applied in experiments with human umbilical vein preparations treated with L-NAME, BQ-123, and BQ-788.
Isometric tension values at the respective PO 2 were averaged in each experiment.
Membrane potential and isometric tension of 29 intact and 23 endothelium-denuded preparations (untreated controls) were recorded. Additionally, we studied seven intact preparations with NO synthase inhibition, five intact and seven endothelium-denuded preparations with ET A receptor antagonism, and six intact and six endothelium-denuded preparations with ETB receptor antagonism. For experiments with and without the respective treatment, we used vessel strips from the same umbilical cords (matched pairs) because the isometric tension generated by a vessel preparation depends on the smooth muscle cell mass, and different umbilical veins have different muscle masses. Thus isometric tension of the preparations treated with L-NAME, BQ-123, and BQ-788 was compared with that of their individual controls without treatment. We had difficulties obtaining a sufficient number of reliable recordings of membrane potential in the matched control preparations. However, membrane potential was recorded in single individual smooth muscle cells and does not depend on the muscle cell mass of a vessel preparation. We therefore thought it reasonable to compare membrane potential recordings of the treated preparations with those of untreated control groups, consisting of all 29 intact preparations and 23 endothelium-denuded preparations, respectively.
To study the concentration-dependent effect of the ET A receptor antagonist BQ-123 at hypoxia, intact preparations were preincubated with either 10 Ϫ5 , 10 Ϫ6 , 10 Ϫ7 , or 0 M BQ-123. The experimental protocol was identical to that described above with the exception that the preparations were exposed to only the low PO 2 range, between 39 and 4 mmHg. We used 24 preparations from 6 umbilical veins. In each preparation, only one concentration of BQ-123 was used. In each set of experiments, all three concentrations of BQ-123 were tested in preparations derived from one umbilical vein and compared with their respective controls without antagonist treatment.
Statistical Analysis
We used ANOVA, followed by Dunnett's test for multiple comparisons to a single control group. For statistical analysis of the differences in isometric tension between treated preparations and their respective matched controls, we used Student's t-test. Differences were considered significant at P Ͻ 0.05. The relationship between membrane potential and isometric tension was tested by linear regression analysis.
RESULTS
Effect of Changes in PO 2 on Membrane Potential and Tone of Human Umbilical Vein Preparations
Intact human umbilical vein preparations (n ϭ 29).
With PO 2 increased from 5 to 104 mmHg, the smooth muscle cell membrane depolarized from Ϫ58.6 Ϯ 1.1 to Ϫ53.3 Ϯ 1.0 mV (P Ͻ 0.001; Table 1 ) and isometric tension increased from 0.673 Ϯ 0.037 to 0.825 Ϯ 0.044 g (P Ͻ 0.02; Fig. 1, open circles) . Compared with the membrane potential and isometric tension at the physiological umbilical venous PO 2 range of 22-35 mmHg (10), these results imply hypoxic hyperpolarization and vasodilatation.
Endothelium-denuded human umbilical vein preparations (n ϭ 23). With PO 2 increased from 5 to 104 mmHg, the smooth muscle cell membrane hyperpolarized from Ϫ51.8 Ϯ 0.3 to Ϫ55.2 Ϯ 0.4 mV (P Ͻ 0.0001). In contrast to intact preparations, endothelium-denuded preparations depolarized when the local PO 2 was decreased from 39 to 5 mmHg (Ϫ54.1 Ϯ 0.3 vs. Ϫ51.8 Ϯ 0.3 mV, P Ͻ 0.0001; Table 2 ). Isometric tension developed by the endothelium-denuded preparations paralleled the changes in membrane potential (Fig. 1, closed squares) . With PO 2 increased from 5 to 104 mmHg, isometric tension decreased from 1.051 Ϯ 0.062 to 0.776 Ϯ 0.029 g (P Ͻ 0.0005). Unlike intact preparations, endothelium-denuded preparations did not exhibit a hypoxic vasodilatation. Lowering PO 2 from 39 to 5 mmHg resulted in an increase in isometric tension from 0.859 Ϯ 0.029 to 1.051 Ϯ 0.062 g (P Ͻ 0.01).
Effect of L-NAME, BQ-123, and BQ-788 on Membrane Potential and Tone of Human Umbilical Vein Preparations at High PO 2
Altogether, neither treatment exerted a significant effect on oxygen-dependent regulation of membrane potential and vascular tone of intact and endotheliumdenuded preparations at the PO 2 range above 39 mmHg (Tables 1 and 2 and Figs. 2 and 3) . However, the membrane potential of intact preparations treated with BQ-788 was more depolarized than that of untreated preparations at 68 mmHg PO 2 .
Effect of L-NAME, BQ-123, and BQ-788 on Membrane Potential and Tone of Human Umbilical Vein Preparations at Low PO 2
At the PO 2 range between 39 and 5 mmHg, intact praparations treated with either L-NAME or BQ-123 were more depolarized than untreated intact preparations (Table 1 ) and revealed pronounced vasoconstriction at low PO 2 values instead of the hypoxic vasodilatation observed in intact preparations without treatment (Fig. 2) . This response to hypoxia corresponded to that of endothelium-denuded preparations without treatment (Table 2 and Fig. 3 ). The lack of hyperpolarization and vasodilatation with decreasing PO 2 after treatment with BQ-123 (10 Ϫ5 M) was also observed if lower concentrations of BQ-123 (10 Ϫ6 and 10 Ϫ7 M) were applied (Table 3 and Fig. 4 ). At the low PO 2 range, intact preparations treated with BQ-788 were more depolarized than untreated controls (Table 1) . Isometric tension remained stable at decreasing PO 2 below 39 mmHg but was not statistically different from isometric tension developed by untreated intact preparations (Fig. 2) .
At the low PO 2 range, membrane potential and isometric tension of endothelium-denuded preparations treated with either BQ-123 or BQ-788 were not different from membrane potential and isometric tension of endothelium-denuded preparations without treatment (Table 2 and Fig. 3 ). Only endothelium-denuded preparations treated with BQ-788 revealed significant membrane hyperpolarization and relaxation at 5 mmHg PO 2 . Fig. 2 . Mean isometric tension Ϯ SE developed by intact human umbilical vein preparations treated with N -nitro-L-arginine methyl ester (L-NAME; 10 Ϫ4 M, n ϭ 7), BQ-123 (10 Ϫ5 M, n ϭ 5), and BQ-788 (10 Ϫ7 M, n ϭ 6), and untreated intact preparations (n ϭ 29) at PO2 values between 5 and 104 mmHg expressed as a percentage of the respective isometric tension developed at 39 mmHg of PO2. Absolute isometric tension measured at 39 mmHg of PO2 was not statistically different between treated preparations and their respective controls. *P Ͻ 0.05 and **P Ͻ 0.01, treated preparations vs. matched controls. Fig. 3 . Mean isometric tension Ϯ SE developed by endothelium-denuded human umbilical vein preparations treated with BQ-123 (10 Ϫ5 M, n ϭ 7) and BQ-788 (10 Ϫ7 M, n ϭ 6), and untreated endothelium-denuded preparations (n ϭ 23) at PO2 values between 5 and 104 mmHg expressed as a percentage of the respective isometric tension developed at 39 mmHg of PO2. Absolute isometric tension measured at 39 mmHg of PO2 was not statistically different between treated preparations and their respective controls. *P Ͻ 0.01, treated preparations vs. matched controls.
Relationship Between Membrane Potential and Isometric Tension
In intact as in endothelium-denuded preparations, isometric tension and intracellular membrane potential at the respective PO 2 values were related linearly (Fig. 5) . In untreated preparations and preparations treated with L-NAME, BQ-788, and BQ-123, respectively, the slopes of these correlations were similar except for the correlation between membrane potential and isometric tension of intact preparations treated with BQ-123 (Table 4) . At all other conditions, a change in membrane potential of 1 mV was related to a change in isometric tension ranging from 0.025 to 0.076 g.
DISCUSSION
In this study, we investigated the possible contribution of endothelial NO and ET to oxygen-dependent regulation of vascular tone of the human umbilical vein. The main findings were that blockade of NO synthase and treatment with either the ET A receptor antagonist BQ-123 or the ET B receptor antagonist BQ-788 abolished the hypoxic hyperpolarization of this vessel. Blockade of NO synthase and treatment with BQ-123 also abolished the concomitant hypoxic vasodilatation. Blockade of ET B receptors on vascular smooth muscle cells restored hypoxic hyperpolarization and relaxation, which were lost after the removal of the endothelium.
Vascular Tone of Human Umbilical Vein at High PO 2
Membrane depolarization and vasoconstriction at increasing PO 2 in intact preparations was little affected by inhibition of NO synthesis or by ET receptor antagonism. The reversed effects of increasing PO 2 after endothelium removal were also independent of ET receptor antagonism. These results indicate that the membrane depolarizing and vasoconstricting effects of high local PO 2 were mediated by a vasoconstricting factor derived from the endothelium of the human umbilical vein different from ET. On the basis of former experiments with cyclooxygenase inhibition (E. Mildenberger, G. Siegel, and H. T. Versmold, unpublished observations), we conclude that endothelial prostanoids mediate human umbilical vein vasoconstriction at high PO 2 . This view is supported by a report (2) of an increased production rate of prostanoids in the human umbilical vein at high PO 2 . Our results further demonstrate that the vasoconstriction of the human umbilical vein at increasing PO 2 was not prevented by NO released from the endothelium.
Vascular Tone of Human Umbilical Vein at Low PO 2
Nitric oxide. Inhibition of NO synthesis in intact preparations resulted in the same response of mem- M) and untreated intact preparations (n ϭ 6 in each respective group of preparations) at PO2 values between 5 and 39 mmHg expressed as a percentage of the respective isometeric tension developed at 39 mmHg of PO2. Absolute isometric tension measured at 39 mmHg of PO2 was not statistically different between treated preparations and their matched controls. *P Ͻ 0.05, **P Ͻ 0.02, ***P Ͻ 0.002, and ****P Ͻ 0.0001, treated preparations vs. controls. brane potential and vascular tone to decreasing PO 2 , as did removal of the endothelium. This suggests that hypoxia stimulated the release of hyperpolarizing and vasodilating NO from the endothelium of the human umbilical vein. Our findings are in contrast to those of others (5, 11) , who did not observe an effect of NO synthase inhibition on hypoxic vasodilatation of rat cerebral arteries and pig coronary arteries. On the other hand, NO appeared to be involved in the hypoxic vasodilatation of rabbit cerebral arteries (18) . This heterogeneity in the response to hypoxia was thought to be tissue specific (18) . In the human umbilical vein, NO obviously plays a major role in hypoxic vasodilatation.
Endothelin. ET A receptor blockade by BQ-123 in intact preparations and ET B receptor blockade by BQ-788 in endothelium-denuded preparations resulted in a reversed response to decreasing PO 2 compared with untreated intact and endothelium-denuded controls. Because none of the ET receptor antagonists used has been described to exhibit agonist activity (8, 9) , we conclude that ET is released from the human umbilical vein vessel wall in response to hypoxia. In the rat mesenteric artery, it has indeed been shown that hypoxia stimulated ET-1 release (19) .
With decreasing PO 2 below 39 mmHg, membrane potential of intact preparations treated with the ET B antagonist BQ-788 was more depolarized than that of untreated controls. This indicates that ET released at hypoxia exerts a hyperpolarizing effect in the human umbilical vein probably by activation of ET B1 receptors on endothelial cells.
The unexpected finding that blockade of ET A receptors, which are known to mediate vasoconstriction, resulted in an increase in isometric tension when the PO 2 was decreased is not easy to explain. It has been suggested that BQ-123, besides blocking ET A receptors on vascular smooth muscle cells, also blocks ET B receptors (17) . In the human umbilical vein such a crossover of BQ-123 to ET B1 receptors on endothelial cells may have resulted in a vasoconstriction that exceeded the vasodilatatory effect of blockade of both the ET A and ET B2 receptors on vascular smooth muscle cells. This again implies that ET released at hypoxia preferentially activated ET B1 receptors on human umbilical vein endothelial cells.
To exclude that the relatively high dose of BQ-123 used (10 Ϫ5 M) caused a nonselective ET receptor blockade, we investigated the effect of decreasing concentrations of BQ-123 (from 10 Ϫ5 to 10 Ϫ7 M). The lack of hyperpolarization and vasodilatation to decreasing PO 2 also occured if lower concentrations than 10 Ϫ5 M BQ-123 were applied. Thus the unexpected finding that blockade of ET A receptors mediating vasoconstriction resulted in vasoconstriction cannot be attributed to a concentration-dependent crossing over of the antagonist to ET B1 receptors mediating vasodilatation. It may, however, still be attributed to a nonselective crossing over that was independent from the concentration of BQ-123 used. An alternative explanation is that BQ-123 may have exerted an intrinsic ET A receptor-activating effect.
In endothelium-denuded preparations, we observed depolarization and vasoconstriction at low PO 2 , which was reversed by ET B receptor antagonism and unaffected by ET A receptor antagonism. Thus ET released by vascular smooth muscle cells of the human umbilical vein (13, 26) at hypoxia may have mediated depolarization and vasoconstriction via activation of ET B2 receptors on human umbilical vein vascular smooth muscle cells, which is in line with the general finding that ET B receptors are predominant on the venous side of the circulation (17) .
Electromechanical Coupling in Human Umbilical Vein
Changes of the vascular tone of the human umbilical vein were closely related to changes in membrane potential of smooth muscle cells. As the relationship between membrane potential and isometric tension was unaffected by treatment with substances blocking the effects of endogenously released NO or ET binding to ET B receptors, respectively, it can be concluded that electromechanical coupling is a principle in the human umbilical vein that is independent from the substance mediating oxygen-dependent changes in vascular tone.
In intact preparations treated with BQ-123, the calculated slope suggests a change in isometric tension of 0.212 g/1 mV change in membrane potential. However, with increasing PO 2 from 5 to 104 mmHg, membrane potential remained virtually identical (54.6 Ϯ 0.7 vs. 54.8 Ϯ 0.9 mV; Table 1 ), whereas isometric tension decreased substantially from 0.939 Ϯ 0.059 to 0.739 Ϯ 0.053 g (P Ͻ 0.05). This indicates electromechcanical uncoupling in the human umbilical vein treated with BQ-123. Together with the unexpected finding of a vasoconstricting effect of BQ-123, these results also point to some extraordinary action of BQ-123.
In summary, our study confirms our previous results of a distinct oxygen-dependent regulation of vascular tone of the human umbilical vein in the physiological umbilical venous PO 2 range that is directly related to vascular smooth muscle cell membrane potential. It further demonstrates that the hypoxic vasodilatation of the human umbilical vein is under the control of NO. Finally, our results provide evidence for the contribution of ET to this hypoxic vasodilatation (Fig. 6) .
